Delivery Order SPE2DB24D1034-SPE2DB25FWCH8
Award Date
4/23/25
Potential Completion Date
5/14/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,372.90 firm-fixed-price contract is for the delivery of "PROQUAD VIALS", a medical product, with a completion date of February 19, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,812.36 firm-fixed-price delivery order is for the supply of PROQUAD VIALS, a medical product, with an ultimate completion date of May 29, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,740.49, is for the delivery of PROQUAD VIALS, a type of medical product. It is a Firm Fixed Price, Delivery Order contract with an ultimate completion date of April 23, 2025. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $13,234.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PROQUAD VIALS, a medical product. It is a firm fixed-price contract with a period of performance through May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a ceiling value of $2,740.40 and a period of performance through May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,543.30 delivery order contract is for the supply of PROQUAD VIALS, a medical product. The contract is a Firm Fixed Price, Delivery Order type with a period of performance through March 11, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $12,537.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of PROQUAD VIALS, a medical product, with an ultimate completion date of October 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,601.99 firm-fixed-price delivery order is for the supply of PROQUAD VIALS, a medical product, with a period of performance through November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $3,203.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a completion date of February 6, 2024. This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,141.08 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a medical product. The contract has an ultimate completion date of November 20, 2024 and was awarded on October 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...